Nantahala Capital Management, LLC

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
133
Total Value
2187261798
Accession Number
0001104659-25-049574
Form Type
13F-HR
CIK
0001472322
Manager Name
Nantahala Capital Management, LLC
Data Enrichment
90% identified
120 identified13 unidentified

Holdings

133 positions
Manager:
SEC
Search and click to pin securities to the top
Page 5 of 7
GAIA, INC
GAIA|36269P104
Shares:
914618(-0.0%)
Value:
$3.5B(-14.3%)
88338H704
88338H704
Shares:
2422563(-9.7%)
Value:
$3.5B(-28.4%)
COLUMBUS MCKINNON CORP
CMCO|199333105
Shares:
200000
Value:
$3.4B
DHI GROUP, INC.
DHX|23331S100
Shares:
2374027(-0.1%)
Value:
$3.3B(-21.6%)
NN INC
NNBR|629337106
Shares:
1441416(-1.2%)
Value:
$3.3B(-31.7%)
EyePoint Pharmaceuticals, Inc.
EYPT|30233G209
Shares:
593091(-1.1%)
Value:
$3.2B(-28.1%)
67577R102
67577R102
Shares:
3157895
Value:
$3.1B
Scully Royalty Ltd.
SRL|G7T96K107
Shares:
368182(-0.1%)
Value:
$3.0B(-12.5%)
Senti Biosciences, Inc.
SNTI|81726A209
Shares:
888000
Value:
$3.0B
Silence Therapeutics plc
SLN|82686Q101
Shares:
1042427(-0.7%)
Value:
$2.9B(-59.3%)
00439U104
00439U104
Shares:
1178203
Value:
$2.7B
Surrozen, Inc./DE
SRZN|86889P208
Shares:
229527(+17.1%)
Value:
$2.7B(-4.8%)
READING INTERNATIONAL INC
RDI|755408101
Shares:
1921088(-32.9%)
Value:
$2.7B(-29.4%)
scPharmaceuticals Inc.
SCPH|810648105
Shares:
995438(-0.5%)
Value:
$2.6B(-26.0%)
Structure Therapeutics Inc.
GPCR|86366E106
Shares:
150000(+0.0%)
Value:
$2.6B(-36.2%)
Keros Therapeutics, Inc.
KROS|492327101
Shares:
250000(+0.0%)
Value:
$2.5B(-35.6%)
ABEONA THERAPEUTICS INC.
ABEO|00289Y206
Shares:
520000(+0.0%)
Value:
$2.5B(-14.5%)
ACHIEVE LIFE SCIENCES, INC.
ACHV|004468500
Shares:
898885(+37.4%)
Value:
$2.4B(+4.3%)
OWENS & MINOR INC/VA/
OMI|690732102
Shares:
200000
Value:
$1.8B
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ASPS|L0175J104
Shares:
2477312(+16.4%)
Value:
$1.7B(+20.6%)